---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-025140"
form_type: "8-K"
ticker: "RNGE"
cik: "0001438943"
company_name: "RANGE IMPACT, INC."
filed_at: "2021-10-12T23:59:59+00:00"
generated_at: "2026-06-28T21:25:00.134148+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vitality Biopharma changes name to Malachite Innovations, adopts dual-subsidiary strategy

## Summary
- Company renamed to Malachite Innovations; effective Oct 12, 2021 trading symbol changes from VBIO to MLCT.
- New operating subsidiary Graphium Biosciences to advance >100 cannabinoid-glycoside compounds, initial focus on inflammatory bowel disease.
- New operating subsidiary Daedalus Ecosciences to invest in environmental solutions for economically challenged communities.
- Fiscal year changed from March 31 to December 31; transition report on Form 10-K for period ending Dec 31, 2021.
- Corporate headquarters relocated from Los Angeles to Cleveland, Ohio.

## SEC filing metadata
- accession: 0001493152-21-025140
- form_type: 8-K
- ticker: RNGE
- cik: 0001438943
- company_name: RANGE IMPACT, INC.
- filed_at: 2021-10-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438943/000149315221025140/0001493152-21-025140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438943/000149315221025140/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-025140
- JSON: https://secwatch.observer/filing/0001493152-21-025140.json
- Plain text: https://secwatch.observer/filing/0001493152-21-025140.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.